NPM1 and colon adenocarcinoma: NPM1 mRNA abundance was also significantly reduced in patients with high-grade colon adenocarcinoma (COAD; stages III and IV), compared to those with low-grade COAD (stages I and II; Extended Data Fig. 1c).